[B! eye] anegishiã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯

anegishi id:anegishi

eyeã«é–¢ã™ã‚‹anegishiã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (12)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

è´ã“ãˆã‚‹ãƒ¡ã‚¬ãƒ HUAWEI Eyewear 2ã€OWNDAYSãƒ¢ãƒ‡ãƒ«ç™ºå£²ã€‚4ã‚¹ã‚¿ã‚¤ãƒ«x2è‰²ã€åº—é ã§ã‚‚è²·ãˆã¾ã™ | ãƒ†ã‚¯ãƒŽã‚¨ãƒƒã‚¸ TechnoEdge
ãƒ¡ã‚¬ãƒãã®ã‚‚ã®ã®å½¢çŠ¶ã§ã‚ã‚ŠãªãŒã‚‰ã€ãƒ„ãƒ«éƒ¨åˆ†ã«ã‚¹ãƒ”ãƒ¼ã‚«ãƒ¼ã¨ãƒžã‚¤ã‚¯ã‚’æè¼‰ã—ã€è€³ã‚’ãµã•ãŒãªã„ã‚ªãƒ¼ãƒ—ãƒ³ã‚¤ãƒ¤ãƒ¼ã‚¹ã‚¿ã‚¤ãƒ«ã§éŸ³æ¥½ã‚„ã‚²ãƒ¼ãƒ ã€é€šè©±ã«ä½¿ãˆã‚‹è£½å“ã§ã™ã€‚ HUAWEI ã¿ãšã‹ã‚‰è²©å£²ã™ã‚‹2ãƒ¢ãƒ‡ãƒ«ã€ã‚¦ã‚§ãƒªãƒ³ãƒˆãƒ³åž‹ãƒãƒ¼ãƒ•ãƒªãƒ ã®ã€Œãƒ–ãƒ©ãƒƒã‚¯ã€ã¯11æœˆ9æ—¥ã€ã€Œãƒã‚¿ãƒ‹ã‚¦ãƒ ã‚·ãƒ«ãƒãƒ¼ã€ã¯11æœˆä»¥é™ç™ºå£²ã§ã™ãŒã€OWNDAYS ã‚³ãƒ©ãƒœã®4ã‚¹ã‚¿ã‚¤ãƒ«2è‰²ã®è¨ˆ8ãƒ¢ãƒ‡ãƒ«ã¯ä¸€è¶³å…ˆã«11æœˆ3æ—¥ã‹ã‚‰è³¼å…¥ã§ãã¾ã™ã€‚ æ˜¨å¹´ã®Eyewear ã‹ã‚‰å¤‰ã‚ã£ãŸã®ã¯ã€ã¾ãšãƒãƒƒãƒ†ãƒªãƒ¼é§†å‹•æ™‚é–“ãŒå¤§å¹…ã«æ”¹å–„ã—ãŸã“ã¨ã€‚ãƒ„ãƒ«ãŒç´°ãå…¨ä½“ã«è»½ãã€ä¸€èˆ¬çš„ãªãƒ¡ã‚¬ãƒã«ã•ã‚‰ã«è¿‘ã¥ã„ãŸã“ã¨ã€‚ HUAWEIãƒ¢ãƒ‡ãƒ«ï¼ˆãƒ–ãƒ©ãƒƒã‚¯ï¼‰æ˜¨å¹´ãƒ¢ãƒ‡ãƒ«ã‚‚éŸ³æ¥½å†ç”Ÿã§6æ™‚é–“ã¨å¿…ãšã—ã‚‚çŸãã¯ãªã‹ã£ãŸã‚‚ã®ã®ã€ç€è„±ã™ã‚‹ã‚¤ãƒ¤ãƒ›ãƒ³ã¨é•ã„ãƒ¡ã‚¬ãƒãªã®ã§1æ—¥ä¸ã‹ã‘ã‚‹ä½¿ã„æ–¹ã‚‚å¤šãã€æŽ¥ç¶šã—ãŸã¾ã¾ã®å¾…æ©Ÿæ™‚é–“ã§ã„ã¤ã®é–“ã«ã‹æ®‹ã‚ŠãŒå°‘ãªããªã‚ŠãŒã¡ã§ã—ãŸã€‚ æ–°åž‹ã¯éŸ³æ¥½å†ç”Ÿã§ç´„11æ™‚é–“ã€é€šè©±ç´„9æ™‚é–“ã€å¾…æ©Ÿ4æ—¥é–“ã€ç€ç”¨ã—ãŸç¾
anegishi 2023/11/06
audioglasses

huawei

eye
ãƒªãƒ³ã‚¯
MITã€è¦–åŠ›è£œæ£æ©Ÿèƒ½ã‚’æŒã£ãŸãƒ‡ã‚£ã‚¹ãƒ—ãƒ¬ã‚¤æŠ€è¡“ã‚’é–‹ç™º ï½žç›®ã§ã¯ãªããƒ‡ã‚£ã‚¹ãƒ—ãƒ¬ã‚¤ã«çœ¼é¡ã‚’ã‹ã‘ã•ã›ã‚‹é€†è»¢ã®ç™ºæƒ³
anegishi 2014/08/07
eye

display
ãƒªãƒ³ã‚¯
è¦–åŠ›ãŒæ‚ªã„äººã§ã‚‚ã€Œè£¸çœ¼ã§ã€ã¯ã£ãã‚Šè¦‹ãˆã‚‹ãƒ‡ã‚£ã‚¹ãƒ—ãƒ¬ã‚¤ã®é–‹ç™ºã«MITãŒæˆåŠŸ
å‹‰å¼·ã‚„ã‚²ãƒ¼ãƒ ã®ã‚„ã‚Šã™ãŽã§ç›®ãŒæ‚ªããªã£ãŸã‚Šã€è¦–åŠ›ã®è‰¯ã„äººã‚‚åŠ é½¢ã«ã¨ã‚‚ãªã£ã¦è¿‘ãã®ç‰©ãŒè¦‹ãˆã«ãããªã‚‹ã€Œè€çœ¼ã€ã«ãªã£ãŸã‚Šã™ã‚‹ã“ã¨ã‚‚ã‚ã‚Šã€ãƒ¡ã‚¬ãƒã‚„ã‚³ãƒ³ã‚¿ã‚¯ãƒˆãƒ¬ãƒ³ã‚ºãªã©ã®è¦–åŠ›ã‚’çŸ¯æ£ã™ã‚‹ãƒ„ãƒ¼ãƒ«ã¯ç¾ä»£äººãŒæ‰‹æ”¾ã›ãªã„ã‚‚ã®ã§ã™ã€‚ã—ã‹ã—ã€ã“ã‚Œã‚‰ã®ç›®ã®è¿‘ãã«ã‚»ãƒƒãƒˆã™ã‚‹ã‚¿ã‚¤ãƒ—ã®è¦–åŠ›çŸ¯æ£ãƒ„ãƒ¼ãƒ«ã¯ã‚ãšã‚‰ã‚ã—ã„ã‚‚ã®ã§ã€ã€Œã§ãã‚‹ã“ã¨ãªã‚‰è£¸çœ¼ã§ã¯ã£ãã‚Šè¦‹ãŸã„ï¼ã€ã¨ã„ã†ã®ãŒå¤§åŠã®äººã®é¡˜ã„ã¨è¨€ãˆã¾ã™ã€‚ãã‚“ãªé¡˜ã„ã‚’ã‹ãªãˆã¦ãã‚Œã‚‹ã€ãƒ‡ã‚£ã‚¹ãƒ—ãƒ¬ã‚¤ã‚¿ã‚¤ãƒ—ã®ã€Œè£¸çœ¼å¯¾å¿œã€è¦–åŠ›çŸ¯æ£ãƒ„ãƒ¼ãƒ«ã®é–‹ç™ºã«ã€MITã¨ã‚«ãƒªãƒ•ã‚©ãƒ«ãƒ‹ã‚¢å¤§å¦ã®å…±åŒç ”ç©¶ãƒãƒ¼ãƒ ãŒæˆåŠŸã—ã¾ã—ãŸã€‚ Vision-correcting displays | MIT News Office http://newsoffice.mit.edu/2014/new-display-techno logy-automatically-corrects-for-vision-defects-0731
anegishi 2014/08/05
eye
ãƒªãƒ³ã‚¯
å‘¨ã‚Šã§ãƒ¬ãƒ¼ã‚·ãƒƒã‚¯ã‚„ã£ãŸäººã¿ã‚“ãªå¤±æ•—ã—ã¦ã‚‹:ãƒãƒ ã‚¹ã‚¿ãƒ¼é€Ÿå ±
1ï¼šä»¥ä¸‹ã€åç„¡ã—ã«ã‹ã‚ã‚Šã¾ã—ã¦VIPãŒãŠé€ã‚Šã—ã¾ã™ï¼š2012/04/17(ç«) 20:06:07.18ID:rHHa1tPT0 æœ¬å½“ã«å¤§ä¸ˆå¤«ãªã®ï¼Ÿ 2ï¼šä»¥ä¸‹ã€åç„¡ã—ã«ã‹ã‚ã‚Šã¾ã—ã¦VIPãŒãŠé€ã‚Šã—ã¾ã™ï¼š2012/04/17(ç«) 20:06:35.10ID:IVJhCZiz0 é§„ç›® 25ï¼šä»¥ä¸‹ã€åç„¡ã—ã«ã‹ã‚ã‚Šã¾ã—ã¦VIPãŒãŠé€ã‚Šã—ã¾ã™ï¼š2012/04/17(ç«) 20:42:48.88ID:lJBGtpB30 ã“ã“ã§ã€Œãƒ¬ãƒ¼ã‚·ãƒƒã‚¯é›£æ°‘ã€ã£ã¦å…¥ã‚Œã¦æ¤œç´¢ã—ã¦ã¿ã€‚çµ¶å¯¾ã«ã‚„ã‚‹ã‚‚ã‚“ã‹ã£ã¦æ€ã†ã‹ã‚‰ã€‚ http://www.lasik-049.com/lasik_taiken/bbs.html |||||||||||||||''|||||||||||||ï¾ž|||||ï¾ž|||''|||||'ï¾ž||||ï¾ž||||||||||ï¾ž|||||||||||||||||||| |||||||||||||ï¾ž || |||
anegishi 2012/05/13
eye

health
ãƒªãƒ³ã‚¯
Innovega INC - Bold Vision. Real Impact.
Almost 300 million people are visually impaired or legally blind, with modern medicine failing to address this. Innovegaâ€™s Eyewear System can restore up to 20/20 visual acuity for this growing community. Isaac Jean-Paul is legally blind and holds a Paralympian world record for high jump. In 2024, he represented the U.S. Paralympian team, competing in the long-jump. Issac recently visited Innovegaâ€™
anegishi 2012/04/15
eye

visualization

display

ui

ar
ãƒªãƒ³ã‚¯
ã€Œè€çœ¼ã€ã®ç—‡çŠ¶ã¯ï¼‘ï¼ä»£ã‹ã‚‰é€²è¡Œã—ã€ã¤ã„ã«ã¯ç„¡é™é ã§ã™ã‚‰â€è¿‘ãã¦è¦‹ãˆãªãâ€ãªã‚‹ï¼ | é›‘å¦ç•Œã®æ¨©å¨ãƒ»å¹³æž—ç´”ã®è€ƒãˆã‚‹ç§‘å¦
ã€Œè¿‘ãã®ã‚‚ã®ãŒã¼ã‚„ã‘ã¦è¦‹ãˆãªããªã‚‹ã€ã¨ã„ã†è€åŒ–ç¾è±¡ã‚’ã€Œè€çœ¼ã€ã¨å‘¼ã³ã¾ã™ã€‚ æ‰‹ã«æŒã£ãŸãƒ¢ãƒŽã‚’çœºã‚ã‚‹ã¨ããªã©ã€ãƒ¢ãƒŽã¾ã§ã®è·é›¢ãŒè¿‘ã„ã¨ã¼ã‚„ã‘ã¦è¦‹ãˆãªã„ã®ã§ã€ãƒ¢ãƒŽã‚’é ãé›¢ã—ã¦çœºã‚ã¦ã„ã‚‹ãŠå¹´å¯„ã‚ŠãŒã„ã¾ã™ã€‚ ã‚ã‚ŒãŒã€è€çœ¼ã§ã™ã€‚ â€¦ã—ã‹ã—ã€ã“ã®è€çœ¼ã€ãŠå¹´å¯„ã‚Šã ã‘ã®å°‚å£²ç‰¹è¨±ã§ã¯ã‚ã‚Šã¾ã›ã‚“ã€‚ å®Ÿã¯ã€è‹¥ã„äººã‚‚ã€Œè€çœ¼ã€ã«ãªã£ã¦ã„ã¾ã™ã€‚ åä»£ã®é ƒã‹ã‚‰ã™ã§ã«ã€æœ¬äººãŒæ°—ã¥ã‹ãªã„ã†ã¡ã«ã€è€çœ¼ã®ç—‡çŠ¶ãŒæ—¥ã€…é€²è¡Œã—ã¦ã„ã‚‹ã®ã§ã™ã€‚ ã€Œçœ¼ãŒãƒ”ãƒ³ãƒˆã‚’åˆã‚ã›ã‚‹èƒ½åŠ›ã€ãŒå¹´é½¢ã«å¿œã˜ã¦ã©ã®ã‚ˆã†ã«å¤‰åŒ–ã™ã‚‹ã‹ã‚’ç¤ºã—ãŸã®ãŒä¸‹ã®ã‚°ãƒ©ãƒ•ã§ã™ã€‚ ã“ã®ã‚°ãƒ©ãƒ•ã¯ã€ã¼ã‚„ã‘ãšã«ï¼ˆã‚‚ã®ã‚’ï¼‰è¦‹ã‚‹ã“ã¨ãŒã§ãã‚‹è·é›¢ï¼ˆï¼åˆç„¦å¯èƒ½è·é›¢ï¼‰ã®ç¯„å›²ã‚’ãƒ¡ãƒ¼ãƒˆãƒ«ï¼ˆmï¼‰ã§è¡¨ã—ã€ãã®ã€Œè¦‹ã‚‹ã“ã¨ãŒã§ãã‚‹è·é›¢ï¼ˆï½ï¼‰ã®é€†æ•°ã€ãŒå¹´é½¢ã«å¿œã˜ã¦ã©ã®ã‚ˆã†ã«å¤‰åŒ–ã™ã‚‹ã‹ã‚’ç¤ºã—ã¦ã„ã¾ã™ã€‚ èµ¤ç·šã¯ã€Œï¼ˆçœ¼ã®ãƒ”ãƒ³ãƒˆã‚’åˆã‚ã›ã‚‹ã“ã¨ãŒã§ãã‚‹ï¼‰æœ€ã‚‚è¿‘ã„è·é›¢ã€ã§ã€é’ç·šãŒã€Œï¼ˆçœ¼ã®ãƒ”ãƒ³ãƒˆã‚’åˆã‚ã›ã‚‹ã“ã¨ãŒã§ãã‚‹ï¼‰æœ€ã‚‚é ã„è·
anegishi 2012/04/12
ãã‚“ãªã«è‹¥ã„é ƒã‹ã‚‰ã‚¸ãƒ¯ã‚¸ãƒ¯æ¥ã¦ãŸã®ã‹ã€‚å…¨ç„¶æ°—ã¥ã‹ãªã‹ã£ãŸã€‚

eye

health
ãƒªãƒ³ã‚¯
è¦–åŠ›ã‚¢ãƒƒãƒ—ã«åŠ¹æžœãŒã‚ã£ãŸè©±é¡Œã®è¦–åŠ›å›žå¾©ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ãƒ™ã‚¹ãƒˆï¼•
ä»Šå›žã¯è©±é¡Œã«ãªã£ãŸè¦–åŠ›ã‚¢ãƒƒãƒ—ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã®ä¸ã‹ã‚‰ å®Ÿéš›ã«åŠ¹æžœã®ã‚ã£ãŸãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°æ–¹æ³•ã‚’ãƒ©ãƒ³ã‚ãƒ³ã‚°å½¢å¼ã§ã¾ã¨ã‚ã¾ã—ãŸã€‚ ä»¥ä¸‹ã®ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã§å®Ÿéš›ã«è¦–åŠ›ãŒå›žå¾©ã—ãŸäººã‚‚å¤šã„ã®ã§ ã€Œæœ€è¿‘ã€è¦–åŠ›ãŒè½ã¡ãŸãªã€ã¨æ„Ÿã˜ã‚‹äººã¯ãœã²ä¸€åº¦å®Ÿè·µã—ã¦ã¿ã¾ã—ã‚‡ã†ã€‚ è¦–åŠ›ã‚’ãã‚“ãã‚“å›žå¾©ã•ã›ã‚‹ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°æ³•BESTï¼• ä¸€åº¦è¦–åŠ›ãŒè½ã¡ã‚‹ã¨ãƒ¬ãƒ¼ã‚·ãƒƒã‚¯æ‰‹è¡“ãªã©ã‚’ã—ãªã„ã¨ å…ƒã®è¦–åŠ›ã¾ã§å›žå¾©ã™ã‚‹ã®ã¯ãªã‹ãªã‹é›£ã—ã„ã§ã™ã€‚ ã—ã‹ã—ã€ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã«ã‚ˆã£ã¦è¦–åŠ›ãŒå›žå¾©ã—ãŸäººã‚‚å¤šã„ã®ã§ ä»¥ä¸‹ã‹ã‚‰åŠ¹æžœã®ã‚ã£ãŸè¦–åŠ›å›žå¾©ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã‚’ä¸€é€šã‚Šå®Ÿè·µã—ã¦ã¿ã¾ã—ã‚‡ã†ã€‚ ç¬¬ï¼‘ä½ 5åˆ†ã®ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã§0.4ã‹ã‚‰1.5ã¾ã§ä¸ŠãŒã£ãŸæ–¹æ³• ãŸã£ãŸã®5åˆ†ã®ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã§0.4ã®è¦–åŠ›ãŒ1.5ã¾ã§ä¸ŠãŒã£ãŸï¼ˆå‹•ç”»ï¼‰ ä¸å·å’Œå®å…ˆç”Ÿï¼ˆç±³å›½åŒ»å¦åšå£«ï¼‰ã®è¦–åŠ›ã‚¢ãƒƒãƒ—ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã€‚ ãƒ†ãƒ¬ãƒ“ã§ã‚‚æ”¾æ˜ ã•ã‚Œã€å®Ÿéš›ã«è¦–åŠ›ã‚‚å¤§ããä¸ŠãŒã£ã¦ã„ãŸãŠã™ã™ã‚ã®æ–¹æ³•ã€‚ å®Ÿè·µã—ã¦ã¿ã¾ã—ãŸãŒã€æœ¬å½“ã«ç›®ã«åŠ¹ã„ã¦
anegishi 2012/01/05
eye

health
ãƒªãƒ³ã‚¯
æ¶™ãŒå‡ºã‚‹ã¾ã§é ãã‚’è¦‹ã‚‹çœ¼ç‹ãƒˆãƒ¬ãƒ¼ãƒ‹ãƒ³ã‚°ã®åŠ¹ç”¨
å€‹äººå·®ãŒã‚ã‚Šã™ãŽã¾ã™ã®ã§ã€ãªã‚‹ã¹ãå¥åº·ãƒã‚¿ã¯ã‚„ã‚‰ãªã„ã‚ˆã†ã«ã—ã¦ã„ãŸã®ã§ã™ãŒã€Twitter ã§ã®ã“ã®ã¤ã¶ã‚„ãã«å¯¾ã—ã¦è³ªå•ãŒã‘ã£ã“ã†ã‚ã£ãŸã®ã§ãˆã„ã‚„ã£ã¨æ›¸ã„ã¦ã¿ã¾ã™ã€‚ ã‚ˆãã€ç–²ã‚Œç›®ã‚„ã€çœ¼ç²¾ç–²åŠ´ã‚’æ”¹å–„ã™ã‚‹ãŸã‚ã«ã€Œé ãã‚’ã¿ãŸã‚‰ã„ã„ã€ãªã©ã¨ã‚ˆãè¨€ã‚ã‚Œã¾ã™ãŒã€ç§ã‚‚ã“ã‚Œã‚’ã»ã¨ã‚“ã©æ¯Žæ—¥ç¹°ã‚Šè¿”ã—ã¦ã„ã¾ã™ã€‚ è¦–åŠ›ãã®ã‚‚ã®ãŒã‚ˆããªã‚‹ã¨ã„ã†ã‚ˆã‚Šã¯ã€ç·Šå¼µã—ã¦ã„ã‚‹çœ¼çƒã®ç‹è‚‰ã‚’ã‚ãˆã¦æ™®æ®µä½¿ã‚ãªã„å´ã«å‘ã‹ã£ã¦ä½¿ã†ã“ã¨ã«ã‚ˆã£ã¦ã€èª¿æ•´ã‚’ã—ã¦ã„ã‚‹ã®ã ã¨ã„ã†ç†è§£ã§ã™ãŒã€ç§ã®å ´åˆã“ã‚Œã‚’æ¥µç«¯ãªãƒ¬ãƒ™ãƒ«ã«ã¾ã§è¿½æ±‚ã™ã‚‹ã¨ã„ã†ç¿’æ…£ã‚’å¦ç”Ÿæ™‚ä»£ã«å§‹ã‚ã¾ã—ãŸã€‚ ãŸã¨ãˆã°é ãã«ã‚ã‚‹å»ºç‰©ã®è¡¨é¢ãŒã‚¿ã‚¤ãƒ«çŠ¶ã ã£ãŸã‚Šã™ã‚‹ã¨ã€ã“ã®ã¨ãç«¯ã‹ã‚‰ç«¯ã¾ã§ã‚¿ã‚¤ãƒ«ãŒã„ãã¤ã‚ã‚‹ã®ã‹æ•°ãˆãŸã‚Šã—ã¾ã™ã€‚ã¾ãŸã€é ãã«æœ¨ç«‹ãŒã‚ã‚‹ã¨ã€ã»ã¨ã‚“ã©è¦‹ãˆã‚‹ã¯ãšã‚‚ãªã„æœ¨ã®è‘‰ã®ä¸€æžšä¸€æžšãŒè¦‹ãˆã‚‹ã‚ˆã†ã«ãªã‚‹ã¾ã§ç›®ã‚’è¦‹é–‹ã„ã¦è¦‹ã¤ã‚ã¾ã™ã€‚å¤œãªã‚‰ä¸€ç›®ã§ã‚ã‹ã‚‹ä¸€ç‰æ˜Ÿãªã©ç„¡è¦–ã—ã¦ã€æš—ã„ç‰ç´šã®æ˜Ÿã‚’æŽ¢ã—ã¾ã™ã€‚
anegishi 2011/09/28
health

eye
ãƒªãƒ³ã‚¯
ãƒ¬ãƒ¼ã‚·ãƒƒã‚¯ä½“é¨“è¨˜ã‚’æ·¡ã€…ã¨æ›¸ã„ã¦ã¿ã‚‹ : ãƒã‚±ã‚¹ã‚¿ç¤¾é•·æ—¥è¨˜
è¦–åŠ›ãŒæ‚ªã„ã®ã§ã™ã€‚ ãªã®ã§ã€ã‚³ãƒ³ã‚¿ã‚¯ãƒˆã‚’ã—ã¦ãŸã®ã§ã™ãŒã€ã“ã‚ŒãŒé¢å€’ãªã®ã§ã™ã€‚é«˜ã„ã—ã€‚ ã¨ã„ã†ã‚ã‘ã§ã€ãƒ¬ãƒ¼ã‚·ãƒƒã‚¯ãªã‚‹ã‚‚ã®ã‚’å—ã‘ãŸã„ãªãã€ã¨æ€ã£ã¦ãŸã®ã§ã™ãã€‚ ã“ã®å‰ã€æ—…è¡Œã§ã‚³ãƒ³ã‚¿ã‚¯ãƒˆãƒ¬ãƒ³ã‚ºã‚’å¿˜ã‚Œã¦å¤§å¤‰ãªç›®ã«ã‚ã£ãŸã®ãŒãã£ã‹ã‘ã§ã€å—ã‘ã‚ˆã†ã¨æ±ºæ„ã—ã¦ã€å…ˆé€±å—ã‘ã¦ãã¾ã—ãŸã€‚ ã©ã†ã ã£ãŸï¼Ÿã¨çµæ§‹èžã‹ã‚Œã‚‹ã®ã§ã€ãƒ¡ãƒ¢ã¨ã—ã¦æ›¸ã„ã¦ã¿ã¾ã™ã€‚ äºˆç´„ ã¨æ€ã£ãŸã‚‰å–„ã¯æ€¥ã’ã¨ã„ã†ã“ã¨ã§ã€ã¨ã‚Šã‚ãˆãšãƒ¬ãƒ¼ã‚·ãƒƒã‚¯ã§æ¤œç´¢ã—ã¦ç—…é™¢æŽ¢ã—ã€‚ ç¥žå¥ˆå·ã‚¯ãƒªãƒ‹ãƒƒã‚¯ã¨ã„ã†ã¨ã“ã‚ãŒã‚ˆã•ã’ã ã£ãŸã®ã§é¸ã‚“ã§ã¿ã¾ã—ãŸã€‚ Webä¸Šã®ãƒ•ã‚©ãƒ¼ãƒ ã§äºˆç´„ã€‚ç°¡å˜ã€‚ æ¤œæŸ»å‰ ã¾ãšã€ãƒ¬ãƒ¼ã‚·ãƒƒã‚¯ã®æ¤œæŸ»ã‚’ã—ãªãã‚ƒã„ã‘ãªã„ã®ã§ã™ãŒã€ãã®ãŸã‚ã«ã€ã‚½ãƒ•ãƒˆã®ã‚³ãƒ³ã‚¿ã‚¯ãƒˆã ã¨1é€±é–“ã€ã‚³ãƒ³ã‚¿ã‚¯ãƒˆã‚’ã—ãªã„æœŸé–“ã‚’ä½œã‚‰ãªã„ã¨ã„ã‘ãªã„ã®ã§ã™ã€‚ ã¨ã„ã†ã‚ã‘ã§ã€ãƒ¡ã‚¬ãƒã‚’ã‹ã£ã¦ã€ãã‚Œã‚’ã‹ã‘ã¦ã„ã¾ã—ãŸã€‚ã“ã‚Œã¯çµæ§‹ã¤ã‚‰ã‹ã£ãŸãƒ»ãƒ»ãƒ»ã€‚ãƒ¡ã‚¬ãƒä¼¼åˆã‚ãªã„ä¸Šã«ã€ã™ã”ã„è‹¦æ‰‹ãªã‚“ã§ã™ã‚ˆ
anegishi 2008/11/15
eye

health
ãƒªãƒ³ã‚¯
ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿è¦–è¦šç—‡å€™ç¾¤ã‚’é˜²ããŸã‚ã®10+ã®ãƒ†ã‚£ãƒƒãƒ—ã‚¹
æ–‡ï¼šSusan Harkinsï¼ˆSpecial to TechRepublicï¼‰Â ç¿»è¨³æ ¡æ£ï¼šæ‘ä¸Šé›…ç« ãƒ»é‡Žå´Žè£•å 2008-10-15 08:00 æœ€è¿‘ã®ç ”ç©¶ã«ã‚ˆã‚Šã€1æ—¥ã«2ã€œ3æ™‚é–“ã—ã‹ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿ã‚’ä½¿ç”¨ã—ãªã„äººã§ã‚‚ç›®ã«é‡å¤§ãªæ‚ªå½±éŸ¿ãŒä¸Žãˆã‚‰ã‚Œã‚‹ã‚ˆã†ã«ãªã‚‹ã“ã¨ã‚‚ã‚ã‚‹ã¨ã„ã†äº‹å®ŸãŒæ˜Žã‚‰ã‹ã«ãªã£ã¦ãã¦ã„ã‚‹ã€‚ãã“ã§æœ¬è¨˜äº‹ã§ã¯ã€ãã†ã„ã£ãŸç›®ã®ç—‡çŠ¶ã«ã¤ã„ã¦ã¾ãšç°¡å˜ã«èª¬æ˜Žã—ã¦ã‹ã‚‰ã€ç›®ã®ç–²ã‚Œã‚’è»½æ¸›ã™ã‚‹ãŸã‚ã®å®Ÿç”¨çš„ãªæ–¹æ³•ã‚’ç´¹ä»‹ã—ã¦ã„ã‚‹ã€‚ ã‚ãªãŸãŒ1æ—¥ã®ã†ã¡2ã€œ3æ™‚é–“ã¯ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿ã«å‘ã‹ã£ã¦ã„ã‚‹ã¨ã„ã†ã®ã§ã‚ã‚Œã°ã€ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿è¦–è¦šç—‡å€™ç¾¤ï¼ˆComputer Vision Syndromeï¼šCVSï¼‰ã«ã‹ã‹ã£ã¦ã„ã‚‹ã‹ã‚‚ã—ã‚Œãªã„ã€‚CVSã®ç—‡çŠ¶ã¨ã—ã¦ã¯é ç—›ã‚„ã€ç„¦ç‚¹ãŒåˆã‚ãªã„ã€ï¼ˆå¼·åº¦ã®ï¼‰ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤ã€ç–²ã‚Œç›®ã€ã‚‚ã®ãŒäºŒé‡ã«è¦‹ãˆãŸã‚Šã‹ã™ã‚“ã§è¦‹ãˆãŸã‚Šã™ã‚‹ã€é¦–ã‚„è‚©ãŒç—›ã‚€ã€ãªã©ãŒã‚ã‚‹ã€‚ ã‚‚ã—ã‚‚ã‚ãªãŸãŒã“ã†ã„ã£ãŸç—‡çŠ¶ã«æ‚©ã¾ã•ã‚Œã¦ã„ã‚‹ã¨ã—ã¦ã‚‚
anegishi 2008/10/16
ã€Œã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿è¦–è¦šç—‡å€™ç¾¤ï¼ˆComputer Vision Syndromeï¼šCVSï¼‰ã€

eye

health
ãƒªãƒ³ã‚¯
ã€ãƒ¬ãƒãƒ¼ãƒˆã€‘ãã‚ãã‚ç›®ã‚’ä¼‘ã‚ã¾ã›ã‚“ã‹? - "ç›®ã«å„ªã—ã„"PCä½œæ¥ã‚’å¦ã¶ | ãƒ©ã‚¤ãƒ• | ãƒžã‚¤ã‚³ãƒŸã‚¸ãƒ£ãƒ¼ãƒŠãƒ«
æ¯Žæ—¥ãƒ‘ã‚½ã‚³ãƒ³ã«å‘ã‹ã£ã¦ã€é•·æ™‚é–“ã®ãƒ‡ã‚¹ã‚¯ä½œæ¥ã€‚ç›®ã¯ç–²ã‚Œã‚‹ã‘ã©ä¼‘ã‚€ã‚ã‘ã«ã‚‚ã„ã‹ãªã„ã€‚ç›®è–¬ã‚’å·®ã—ã¦ä½œæ¥ç¶šè¡Œã€‚ãã†ã„ãˆã°ä»¥å‰ã‚ˆã‚Šè‚©ã“ã‚Šã€é ç—›ãŒã²ã©ããªã£ãŸæ°—ãŒâ€¦â€¦ã€‚ãã‚“ãªæ—¥å¸¸ã‚’é€ã£ã¦ã„ã‚‹æ–¹ã«è³ªå•ã—ãŸã„ã€‚åŒã˜PCä½œæ¥ã§ã‚‚ç›®ã®ç–²ã‚Œã‚’è»½æ¸›ã§ãã‚‹ä½œæ¥ã®ä»•æ–¹ãŒã‚ã‚‹ã®ã‚’ã”å˜çŸ¥ã ã‚ã†ã‹ã€ã¨ã€‚ä»Šå›žã¯VDTã‚¤ãƒ³ã‚¹ãƒˆãƒ©ã‚¯ã‚¿ãƒ¼ã‚‚çŽ‡ã„ãŸãƒŠãƒŠã‚ªã®ãƒ—ãƒ¬ã‚¹å‘ã‘ã‚»ãƒŸãƒŠãƒ¼ã€Œçœ¼ç²¾ç–²åŠ´ã‚»ãƒŸãƒŠãƒ¼ã€ã§ã€"ç›®ã«å„ªã—ã„"PCä½œæ¥ã«ã¤ã„ã¦ä¼æŽˆã—ã¦ã„ãŸã ã„ãŸã€‚ VDT(Visual Display Terminal)ç—‡å€™ç¾¤ çœ¼ç²¾ç–²åŠ´ã®ä¸»ãªç—‡çŠ¶ã¯çœ¼ç–²åŠ´(ç›®ãŒä¹¾ãã€ç›®ã®å¥¥ãŒç—›ã„ã€ã‚·ãƒ§ãƒœã‚·ãƒ§ãƒœã™ã‚‹ç‰)ã®ç—‡çŠ¶ã«åŠ ãˆã¦ã€ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤ã‚„ç›®ã¾ã„ã€é ç—›ã€è‚©ã“ã‚Šã€åãæ°—ãªã©ãŒæŒ™ã’ã‚‰ã‚Œã‚‹ã€‚ãã®ä¸ã§ä»Šå›žæ‰±ã†ã®ã¯ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤ã®ä¸€å› ã¨ã‚‚è¨€ã‚ã‚Œã‚‹"VDTç—‡å€™ç¾¤"å¯¾ç–ã ã€‚ VDT(Visual Display Terminal)ç—‡å€™ç¾¤ã¨ã¯ã€ã‚³ãƒ³ãƒ”ãƒ¥ãƒ¼ã‚¿ãƒ¢ãƒ‹ã‚¿ãƒ¼ãªã©ã®è¡¨ç¤ºæ©Ÿå™¨(VD
anegishi 2008/07/15
eye

display

health
ãƒªãƒ³ã‚¯
ç¬¬1å›žã€€çœ¼ã®ç–²ã‚Œã‚’å–ã‚‹ï¼šITpro
ã‚·ã‚¹ãƒ†ãƒ ã®é–‹ç™ºãƒ»é‹ç”¨ã¨ã„ã†æ¿€å‹™ã‚’ç¶šã‘ã¦ã„ã‚‹ã¨ï¼Œã„ã¤ã®é–“ã«ã‹å¿ƒèº«ã«ç–²ã‚ŒãŒãŸã¾ã‚‹ã‚‚ã®ã€‚ååˆ†ã«ä¼‘é¤Šã‚’å–ã‚Œãšï¼Œçœ¼ï¼Œè‚©ï¼Œè…°ãªã©ã«è¾›ã•ã‚’æ„Ÿã˜ã¦ã„ã‚‹æ–¹ã‚‚å¤šã„ã®ã§ã¯ãªã„ã§ã—ã‚‡ã†ã‹ã€‚ ãã“ã§ï¼ŒãŠè–¦ã‚ã—ãŸã„ã®ãŒï¼Œè‡ªåˆ†ã§ãƒ„ãƒœï¼ˆçµŒç©´ï¼‰ã‚’ãƒžãƒƒã‚µãƒ¼ã‚¸ã™ã‚‹ã“ã¨ã§ã™ã€‚ãƒžãƒƒã‚µãƒ¼ã‚¸ã«ã‚ˆã£ã¦ãƒ„ãƒœã‚’åˆºæ¿€ã™ã‚Œã°ï¼Œç–²ã‚ŒãŒå’Œã‚‰ã„ã§å¿ƒèº«ãŒã™ã£ãã‚Šã—ã¾ã™ã€‚å¥åº·ã‚’ä¿ã¤ã®ã«å½¹ç«‹ã¤ã ã‘ã§ãªãï¼Œä»•äº‹ã¸ã®é›†ä¸åŠ›ã‚’é«˜ã‚ã‚‹ã“ã¨ã«ã‚‚ã¤ãªãŒã‚Šã¾ã™ã€‚ä»•äº‹ã®åˆé–“ãªã©ã¡ã‚‡ã£ã¨æ™‚é–“ãŒç©ºã„ãŸã¨ãã‚’åˆ©ç”¨ã—ã¦ï¼Œãœã²ãƒ„ãƒœã®ãƒžãƒƒã‚µãƒ¼ã‚¸ã‚’ç¿’æ…£åŒ–ã—ã¦ãã ã•ã„ã€‚ ã“ã®é€£è¼‰ã§ã¯æ¯Žå›žï¼Œè‚©ã“ã‚Šã‚„è…°ã®ç—›ã¿ã¨ã„ã£ãŸä¸€ã¤ã®ç—‡çŠ¶ã‚’å–ã‚Šä¸Šã’ï¼Œãã‚Œã«å¯¾ã—ã¦åŠ¹æžœãŒå¤§ããï¼Œè‡ªåˆ†ã§ãƒžãƒƒã‚µãƒ¼ã‚¸ã—ã‚„ã™ã„ãƒ„ãƒœã‚’ç´¹ä»‹ã—ã¦ã„ãã¾ã™ã€‚ä»Šå›žã¯ï¼Œçœ¼ã®ç–²ã‚Œã‚’å–ã‚‹å…«ã¤ã®ãƒ„ãƒœã‚’ç´¹ä»‹ã—ã¾ã™ã€‚ çœ¼ã®å‘¨ã‚Šã«ã‚ã‚‹å…ã¤ã®ãƒ„ãƒœãŒç–²ã‚Œã«åŠ¹ã çœ¼ã®ç–²ã‚Œã‚’æ„Ÿã˜ãŸã¨ãï¼Œç„¡æ„è˜ã«ç›®é ã‚’æŠ¼ã•ãˆãŸçµŒé¨“ã¯ã‚ã‚Šã¾ã›ã‚“ã‹ã€‚çœ¼ã®ç–²ã‚Œã‚’å–ã‚‹ã†ãˆã§åŠ¹æžœçš„ãªãƒ„ãƒœã®
anegishi 2008/04/21
pc

eye

health
ãƒªãƒ³ã‚¯
1